PMTUMEDIUM SIGNALFINANCIAL10-K

PMTU substantially expanded its balance sheet while experiencing a sharp increase in interest expenses that pressured profitability despite revenue growth.

The company grew its asset base by nearly 50% to $21.3 billion, suggesting an aggressive expansion strategy, but the accompanying rise in liabilities and substantially higher interest costs indicate increased leverage and funding pressures. The decline in net income despite revenue growth signals margin compression from higher financing costs, which could concern investors about the sustainability of the expansion strategy.

Comparing 2026-02-18 vs 2025-02-20View on EDGAR →
FINANCIAL ANALYSIS

PMTU demonstrated significant balance sheet growth with total assets expanding 48% to $21.3 billion and liabilities increasing 56% to $19.5 billion, indicating substantial business expansion funded primarily through debt. While revenue grew a solid 10% to $351 million, interest expenses rose substantially, causing net income to decline 21% to $128 million and reflecting meaningful margin pressure. The company also reduced dividend payments by 24% and saw cash positions decline, suggesting tighter liquidity management amid the rapid expansion.

FINANCIAL STATEMENT CHANGES
Interest Expense
P&L
+79.3%
$410.4M$736.0M

Interest expense surged 79.3% — significant debt increase or rising rates materially impacting earnings.

Total Liabilities
Balance Sheet
+56%
$12.5B$19.5B

Liabilities grew 56% — significant increase in debt or obligations, assess impact on financial flexibility.

Total Assets
Balance Sheet
+48.2%
$14.4B$21.3B

Asset base grew 48.2% — expansion through organic growth, acquisitions, or capital deployment.

Dividends Paid
Cash Flow
-24%
$173.0M$131.6M

Dividend reduced 24% — monitor management commentary on capital allocation priorities.

Cash & Equivalents
Balance Sheet
-22.9%
$77.6M$59.8M

Cash decreased 22.9% — monitor burn rate and upcoming capital needs.

Net Income
P&L
-20.6%
$161.0M$127.9M

Net income declined 20.6% — review whether driven by operations, interest costs, or non-recurring items.

Revenue
P&L
+10.4%
$317.9M$351.1M

Revenue growing 10.4% — solid top-line momentum, watch margins for quality of growth.

LANGUAGE CHANGES
NEW — 2026-02-18
PRIOR — 2025-02-20
ADDED
As of February 13, 2026, there were 87,016,604 comm on shares of the registrant outstanding.
We also invest in Agency and senior non-Agency MBS, subordinate MBS, interest-only ("IO"), principal-only ("PO") stripped MBS and Agency floating rate collateralized mortgage obligations ("CMOs").
A significant portion of our business involves Government-Sponsored Enterprises ("GSEs"), specifically the Federal Home Loan Mortgage Corporation ("Freddie Mac") and the Federal National Mortgage Association ("Fannie Mae").
Freddie Mac and Fannie Mae are each referred to as an Agency and, collectively as the "Agencies".
We operate our business in three segments: credit sensitive strategies, interest rate sensitive strategies and correspondent production.
+7 more — sign up free →
REMOVED
As of February 17, 2025, there were 86,860,960 common shares of the registrant outstanding.
We also invest in Agency and senior non-Agency MBS, subordinate credit-linked MBS and interest-only ("IO") and principal-only ("PO") stripped MBS.
We have also historically invested in distressed mortgage assets (distressed loans and real estate acquired in settlement of loans ( REO )), which we have substantially liquidated.
Our business includes three segments: credit sensitive strategies, interest rate sensitive strategies and correspondent production.
The interest rate sensitive strategies segment represents our investments in MSRs (including both base servicing and excess servicing spread ( ESS ), collectively referred to as MSR), Agency and senior non-Agency MBS and the related interest rate hedging activities.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →